+ Follow PHARMACEUTICAL LABORATORY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 86477
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 90634
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 86328
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[3] => Array
(
[ArticleID] => 104091
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
)
)
PHARMACEUTICAL LABORATORY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 86477
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 90634
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 86328
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[3] => Array
(
[ArticleID] => 104091
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
)
)
abtest
